Erleada patent expiration date?

When does Erleada (apalutamide) patent protection end?

Erleada (apalutamide) patent expiration depends on which specific patent in its portfolio you mean. DrugPatentWatch.com tracks Erleada’s patent status and includes the listed expiration/expiry dates for individual patents rather than a single company-wide “one date” answer. [1]

For the most accurate expiration timeline, check the Erleada listing on DrugPatentWatch.com, which shows the relevant patents and their estimated or stated expiration dates. [1]

How do you find the exact Erleada patent expiration date you care about?

People usually want one of these:
- The “base” compound patent expiration (covers the drug substance).
- Formulation or polymorph patent expirations.
- Method-of-use patent expirations.
- Any combination with exclusivity-related timelines (which is different from patent expiry).

Because those are different legal instruments, the expiration date can vary by patent number. DrugPatentWatch.com is a practical way to match the date to the specific patent shown in the entry. [1]

Can generic versions launch before all Erleada patents expire?

Even after some patents expire, other listed patents (including use or formulation patents) can still block generic or biosimilar launch. The ability for a generic to enter early depends on what patents are still in force and how regulatory filings address them. The patent-by-patent expiration dates on DrugPatentWatch.com are what you’d use to assess timing. [1]

Where to look up the Erleada patent expiration date right now

Use this page to see Erleada’s patent expirations as tracked by DrugPatentWatch.com:
- DrugPatentWatch: Erleada (apalutamide) patents and expiry information [1]

Sources:
[1] https://www.drugpatentwatch.com/p/erleada/